The same broken gene appears in both species—that's a clue.
Em laboratórios espalhados por três continentes, cientistas descobriram que o câncer fala uma linguagem genética comum entre humanos e gatos domésticos — uma revelação que desafia a fronteira entre a medicina veterinária e a oncologia humana. Ao mapear tumores de quase quinhentos felinos em cinco países, pesquisadores identificaram mutações compartilhadas que não apenas explicam a agressividade de certos cânceres de mama, mas também sugerem caminhos terapêuticos que podem beneficiar ambas as espécies. O estudo, publicado na revista Science, convida a ciência a reconhecer que a biologia do adoecimento não respeita a distinção entre o humano e o animal.
- O câncer é uma das principais causas de morte em gatos domésticos, mas sua genética permanecia quase completamente desconhecida até agora.
- A mutação no gene FBXW7, encontrada em mais da metade dos tumores mamários felinos analisados, é a mesma associada a cânceres de mama mais agressivos em humanos — uma coincidência que não pode ser ignorada.
- Quimioterápicos testados contra tumores felinos com essa mutação específica mostraram eficácia aumentada, abrindo uma janela terapêutica potencialmente válida para as duas espécies.
- A hipótese de que gatos e humanos compartilham riscos ambientais por conviverem nos mesmos espaços adiciona uma dimensão nova e inquietante à pesquisa sobre carcinogênese.
- A abordagem 'One Medicine' emerge como resposta: um modelo colaborativo em que ensaios clínicos veterinários e humanos se alimentam mutuamente, acelerando a busca por tratamentos eficazes.
Uma equipe de pesquisadores suíços, em colaboração com cientistas do Reino Unido e do Canadá, realizou o primeiro mapeamento genético em larga escala de cânceres em gatos domésticos. Analisando amostras de tumores de quase quinhentos animais em cinco países, o estudo revelou algo surpreendente: a arquitetura genética do câncer felino se assemelha, em pontos fundamentais, à do câncer humano.
Entre as descobertas mais significativas está a mutação no gene FBXW7, presente em mais da metade dos tumores mamários agressivos estudados nos felinos — o mesmo gene que, quando alterado em humanos, está associado a cânceres de mama de pior prognóstico. Mais do que uma coincidência biológica, a descoberta teve implicações práticas imediatas: certos quimioterápicos demonstraram maior eficácia justamente nos tumores com essa mutação, sugerindo uma via terapêutica com potencial para ambas as espécies.
Sven Rottenberg, pesquisador sênior da Universidade de Berna e um dos autores do estudo, destacou que o acesso a um repositório tão amplo de tecidos doados foi essencial para avaliar respostas a medicamentos em diferentes tipos de tumor numa escala inédita. O trabalho também levantou uma hipótese instigante: como gatos convivem nos mesmos ambientes que seus tutores, parte dos riscos oncológicos pode derivar de exposições ambientais compartilhadas.
O estudo aponta para o modelo conhecido como 'One Medicine', que propõe uma troca contínua de conhecimento entre a medicina veterinária e a humana. Nessa perspectiva, tratamentos já utilizados em oncologia humana poderiam ser testados em gatos, enquanto dados clínicos felinos informariam futuros ensaios com pacientes humanos. A conclusão subjacente é simples e profunda: o câncer não é um problema exclusivamente humano, e as respostas podem vir de onde menos se espera.
A Swiss research team has discovered that the genetic architecture of cancer in domestic cats mirrors human tumors in striking ways—a finding that could reshape how oncologists approach treatment for both species. The study, published in Science, represents the first large-scale genetic mapping of feline cancers, analyzing tumor samples from nearly five hundred cats across five countries to understand the mutations driving the disease.
Cancer ranks among the leading causes of illness and death in domestic cats, yet until now, little was known about its genetic origins. The researchers set out to change that by collecting and sequencing tumor tissue from cats in clinics and research centers worldwide. What they found was a genetic language that transcends species: many of the same genes implicated in human cancers were mutated in feline tumors. The team identified mutations in cancers affecting the breast, blood, bone, lung, skin, gastrointestinal tract, and central nervous system—a catalog of overlap that suggests fundamental biological similarities in how cancer develops across mammalian species.
The most striking discovery involved aggressive breast cancers in cats. In more than half of the feline breast tumor samples, researchers found mutations in a gene called FBXW7. This same gene, when mutated in human breast cancer, is associated with worse outcomes and more aggressive disease. The parallel was unmistakable. But the finding went further: when the team tested certain chemotherapy drugs against feline breast tumors carrying the mutated FBXW7 gene, those drugs showed enhanced effectiveness. The implication was immediate—a potential therapeutic pathway that might work in both cats and humans.
Sven Rottenberg, a senior author of the study from the University of Berna in Switzerland, emphasized the significance of having access to such a large tissue repository. "Having access to such a large collection of donated tissues allowed us to evaluate drug responses across different tumor types in a way that had never been possible at this scale," he explained. The work involved collaboration across three continents: researchers from the Wellcome Sanger Institute in the United Kingdom and the Ontario Veterinary College at the University of Guelph in Canada joined the Swiss team.
The research also surfaced an intriguing hypothesis: because domestic cats live in the same environments as their owners, some cancer risks may stem from shared environmental exposures. This observation opens a new dimension to understanding carcinogenesis—the possibility that studying feline tumors could illuminate how household exposures affect human health.
The findings point toward a collaborative model known as "One Medicine," an approach that encourages knowledge exchange between veterinary researchers and human physicians to improve health outcomes across species. Under this framework, treatments already in use for human cancer could eventually be tested in cats, while clinical data from feline studies could inform future human trials. The strategy acknowledges a fundamental truth: cancer is not a uniquely human problem, and the solutions may come from unexpected places—including the animals sleeping on our couches.
Citações Notáveis
Having access to such a large collection of donated tissues allowed us to evaluate drug responses across different tumor types in a way that had never been possible at this scale.— Sven Rottenberg, senior author, University of Berna
A Conversa do Hearth Outra perspectiva sobre a história
Why does cancer in cats matter to human medicine? Aren't they just different species?
They're different, yes, but the cancer itself speaks the same genetic language. When you find the same broken gene in a cat's tumor and a human's tumor, you're looking at a shared vulnerability. That's a clue.
So the FBXW7 gene—that's the big finding?
It's one of them. What made it significant is that it appeared in over half the feline breast tumors they studied, and when they tested drugs against those tumors, certain chemotherapies worked better. That's not just correlation; that's a potential treatment signal.
But they only tested it in tissue samples, right? Not in living cats?
Correct. This is foundational work—mapping the genetic landscape. The next step would be clinical trials, which is where the "One Medicine" approach becomes powerful. You could test a human drug in cats first, or vice versa, and accelerate what would normally take years.
Why haven't researchers done this before?
Scale and access. You need hundreds of tumor samples from multiple countries, genetic sequencing capacity, and collaboration across veterinary and human medicine. Those pieces didn't align until now. Most cancer research in animals has been fragmented or focused on dogs.
The shared environment angle—is that speculative?
It's a hypothesis that emerged from the data, not proven. But it's worth pursuing. If cats and humans living together develop similar cancers, that suggests something in their shared space—air, water, food, chemicals—might be driving it. That's a public health question.
What happens next?
Clinical trials in cats with certain human cancer drugs, probably. And human trials informed by what they learn from cats. It's a two-way street now.